Significance of Inflammation Marker of Radionecrosis in Laryngopharynx Cancer Treated With Radiation | Canada Hyperbarics
Study Laryngoscope 2026

Significance of Inflammation Marker of Radionecrosis in Laryngopharynx Cancer Treated With Radiation

Kim J, Yi S, Kwon M, Jung Y, Choi S, Lee Y — Laryngoscope, 2026

Tier 2 — Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers examined whether early HBOT in patients with laryngopharyngeal radionecrosis improved organ preservation rates and reduced the need for surgical resection.

What They Found

Patients who received HBOT early in the course of radionecrosis had significantly higher rates of organ preservation compared to those treated later or without HBOT. Early intervention appeared to reverse ischemic tissue damage before permanent necrosis developed.

What This Means for Canadian Patients

Laryngopharyngeal radionecrosis is a devastating complication for head and neck cancer survivors. Early referral for HBOT at Canadian centres could help preserve speech and swallowing function in affected patients.

Canadian Relevance

Covers an OHIP-covered indication: delayed radiation injury (radionecrosis). Ontario patients with radiation-induced tissue necrosis of the larynx or pharynx may be eligible for publicly funded HBOT.

Study Limitations

The retrospective design and variation in timing of HBOT referral introduce selection bias in outcome comparisons.

Was this summary helpful?

Study Details

Study Type Study
Category Radiation Injury
Source Pubmed
PubMed ID 40874727
Year Published 2026
Journal Laryngoscope
MeSH Terms Humans; Male; Retrospective Studies; Female; Middle Aged; Radiation Injuries; Aged; Necrosis; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Hyperbaric Oxygenation; Inflammation; Neutrophils; Treatment Outcome; Biomarkers; Aged, 80 and over

Cite This Study

Share

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.